Effects of NQO1 deficiency on levels of cyclopurines and other oxidative DNA lesions in liver and kidney of young mice

International Journal of Cancer

Volumn 112, Issue 5, 2004, Pages 877-883

  Zhou, Guo Dong ^a,c   Randerath, Kurt ^b   Donnelly, Kirby C ^a   Jaiswal, Anil K ^b  

^a TEXAS A AND M UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

8,5 cyclo 2 deoxyadenosine; 32P postlabeling; Adduct; NAD(P)H:quinone oxidoreductase 1; Oxidative DNA lesion; Reactive oxygen species; Type II I compound

Indexed keywords

ANTIOXIDANT; DEOXYADENOSINE; PURINE DERIVATIVE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

AGE DISTRIBUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; DETOXIFICATION; DNA DAMAGE; ENZYME ACTIVITY; ENZYME DEFICIENCY; FEMALE; KIDNEY; LIVER; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; SPECTROPHOTOMETRY; STATISTICAL SIGNIFICANCE; WESTERN BLOTTING; WILD TYPE;

ANIMALS; BLOTTING, WESTERN; DNA ADDUCTS; DNA DAMAGE; KIDNEY; LIVER; MICE; NADPH DEHYDROGENASE; OXIDATIVE STRESS; PURINES; REACTIVE OXYGEN SPECIES; SPECTROPHOTOMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 7244240598     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20375     Document Type: Article

References (62)

1. 32P-postlabeling in DNA modified by oxidative damage in vitro: comparison with rat lung compounds. Mutat Res 1991;250:135-44.
2. Randerath K, Hart RW, Zhou GD, Reddy R, Danna TF, Randerath E. Enhancement of age-related increases in DNA I-compound levels by calorie restriction: comparison of male B-N and F-344 rats. Mutat Res 1993;295:31-46.
3. Randerath K, Zhou GD, Hart RW, Turturro A, Randerath E. Biomarkers of aging: correlation of DNA I-compound levels with median lifespan of calorically restricted and ad libitum fed rats and mice. Mutat Res 1993;295:247-63.
4. Randerath E, Zhou G-D, Randerath K. Organ-specific oxidative DNA damage associated with normal birth in rats [erratum in Carcinogenesis 1997;18:859-66]. Carcinogenesis 1996;17:2563-70.
5. Vulimiri SV, Zhou G-D, Randerath K, Randerath E. High levels of endogenous DNA adducts (I-compounds) in pig liver. Modulation by high cholesterol/high fat diet. Mutat Res 1998;422:297-311.
6. Randerath K, Randerath E, Zhou GD, Li D. Bulky endogenous DNA modifications (I-compounds) - possible structural origins and functional implications. Mutat Res 1999;424:183-94.
7. Zhou GD, Hernandez NS, Randerath E, Randerath K. Effects of different diets and dietary restriction on perinatal endogenous DNA adducts. Time dependence of oxidative and presumptive nonoxidative lesions. Mutat Res 2000;447:137-47.
8. 32P-postlabeling assay and possible significance for spontaneous tumor induction and aging. Carcinogenesis 1986;7:1615-7.
9. Li D, Chen S, Randerath K. Natural dietary ingredients (oats and alfalfa) induce covalent DNA modifications (I-compounds) in rat liver and kidney. Nutr Cancer 1992;17:205-16.
10. Liehr JG, Avitts TA, Randerath E, Randerath K. Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. Proc Natl Acad Sci USA 1986;83:5301-5.
11. Randerath K, Putman KL, Randerath E, Mason G, Kelley M, Safe S. Organ-specific effects of long term feeding of 2,3,7,8-tetrachlorodibenzo-p- dioxin and 1,2,3,7,8-pentachlorodibenzo-p-dioxin on I-compounds in hepatic and renal DNA of female Sprague-Dawley rats. Carcinogenesis 1988;9:2285-9.
12. Randerath E, Zhou G-D, Hart RW, Randerath K. Age-dependent indigenous covalent DNA modifications (I-compounds). In: Hart RW, Neumann DA, Robertson RT, eds. Dietary restriction: implications for the design and interpretation of toxicity and carcinogenicity studies. Washington DC: ILSI Press, 1995. 229-44.
13. Randerath E, Watson WP, Zhou GD, Chang J, Randerath K. Intensification and depletion of specific bulky renal DNA adducts (I-compounds) following exposure of male F344 rats to the renal carcinogen ferric nitrilotriacetate (Fe-NTA). Mutat Res 1995;341:265-79.
14. Zhou GD, Randerath E, Randerath K. Effects of dietary transition metals on oxidative DNA lesions in newborn rats. Mutat Res 2001;479:71-9.
15. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′- deoxyguanosine, as a marker of cellular oxidative stress during carcinogenesis. Mutat Res 1997;387:147-63.
16. Kawanishi S, Hiraku Y, Oikawa S. Mechanism of guanine-specific DNA damage by oxidative stress and its role in carcinogenesis and aging. Mutat Res 2001;488:65-76.
17. Lin PH, Nakamura J, Yamaguchi S, La DK, Upton PB, Swenberg JA. Induction of direct adducts, apurinic/apyrimidinic sites and oxidized bases in nuclear DNA of human HeLa S3 tumor cells by tetrachlorohydroquinone. Carcinogenesis 2001;22:635-9.
18. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 1986;7:1543-51.
19. 32P-postlabeling assay for the oxidative DNA lesions 8,5′-cyclo-2′-deoxyadenosine in mammalian tissues. J Biol Chem 2001;276:36051-7.
20. 32P-postlabelling of DNA adducts induced by a Fenton-type oxygen radical-generating system. Carcinogenesis 1992;13:1127-35.
21. Randerath K, Randerath E, Smith CV, Chang J. Structural origins of bulky oxidative DNA adducts (type II I-compounds) as deduced by oxidation of oligonucleotides of known sequence. Chem Res Toxicol 1996;9:247-54.
22. Brooks PJ, Wise DS, Berry DA, Kosmoski JV, Smerdon MJ, Somers RL, Mackie H, Spoonde AY, Ackerman EJ, Coleman K, Tarone RE, Robbins JH. The oxidative DNA lesion 8,5′-(S)-cyclo-2′-deoxyadenosine is repaired by the nucleotide excision repair pathway and blocks gene expression in mammalian cells. J Biol Chem 2000;275:22355-62.
23. Kuraoka I, Bender C, Romieu A, Cadet J, Wood RD, Lindahl T. Removal of oxygen free-radical-induced 5′,8-purine cyclodeoxynucleosides from DNA by the nucleotide excision-repair pathway in human cells. Proc Natl Acad Sci USA 2000;97:3832-7.
24. Kuraoka I, Robins P, Masutani C, Hanaoka F, Gasparutto D, Cadet J, Wood RD, Lindahl T. Oxygen free radical damage to DNA. Translesion synthesis by human DNA polymerase η and resistance to exonuclease action at cyclopurine deoxynucleoside residues. J Biol Chem 2001;276:49283-8.
25. Satoh MS, Jones CJ, Wood RD, Lindahl T. DNA excision-repair defect of xeroderma pigmentosum prevents removal of a class of oxygen free radical-induced base lesions. Proc Natl Acad Sci USA 1993;90:6335-9.
26. Shaw PM, Reiss A, Adesnik M, Nebert DW, Schembri J, Jaiswal AK. The human dioxin-inducible NAD(P)H:quinone oxidoreductase cDNA-encoded protein expressed in COS-1 cells is identical to diaphorase 4. Eur J Biochem 1991;195:171-6.
27. Joseph P, Jaiswal AK. NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adduces generated by cytochrome P4501A1 and P450 reductase. Proc Natl Acad Sci USA 1994;91:8413-7.
28. Jaiswal AK. Regulation of genes encoding NAD(P)H:quinone oxidoreductases. Free Radic Biol Med 2000;29:254-62.
29. Long II DJ, Waikel RL, Wang XJ, Perlaky L, Roop DR, Jaiswal AK. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a)pyrene-induced mouse skin carcinogenesis. Cancer Res 2000;60:5913-5.
30. Long II DJ, Waikel RL, Wang XJ, Roop DR, Jaiswal AK. NAD(P)H: quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12-dimethylbenz[a] anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst 2001;93:1166-70.
31. Malkinson AM, Siegel D, Forrest GL, Gazdar AF, Oie HK, Chan DC, Bunn PA, Mabry M, Dykes DJ, Harrison SD. Elevated DT-diaphorase activity and messenger RNA content in human non-small cell lung carcinoma: relationship to the response of lung tumor xenografts to mitomycin Cl. Cancer Res 1992;52:4752-7.
32. Radjendirane V, Joseph P, Jaiswal AK. Gene expression of DT diaphorase (NQO1) in cancer cells. In: Forman HJ, Cadenas E, eds. Oxidative stress and signal transduction. New York: Chapman & Hall, 1997. 441-75.
33. Radjendirane V, Joseph P, Lee YH, Kimura S, Klein-Szanto AJ, Gonzalez FJ, Jaiswal AK. Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 1998;273:7382-9.
34. 32P-labeling test for DNA damage. Proc Natl Acad Sci USA 1981;78:6126-9.
35. 32P- postlabeling. Mutat Res 1993;291:147-59.
36. Gupta RC. Non-random binding of the carcinogen N-hydroxy-2- acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci USA 1984;81:6943-7.
37. 32P-postlabeling assay of DNA adducts from 1,2:3,4-diepoxybutane, the most genotoxic metabolite of 1,3-butadiene: in vitro methodological studies and in vivo dosimetry. Mutat Res 1996;371:87-104.
38. Zhou G-D, Hernandez NS, Randerath E, Randerath K. Acute elevation by short-term dietary restriction or food deprivation of type I I-compound levels in rat liver DNA. Nutr Cancer 1999;35:87-95.
39. Jaiswal AK, Burnett P, Adesnik M, McBride OW. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6. Biochemistry 1990;29:1899-906.
40. Zar JH. Biostatistical analysis. Englewood Cliffs, NJ: Prentice-Hall, 1999.
41. Packer L. Oxidative stress, antioxidants, aging and disease. In: Cutler RG, Packer L, Bertram J, Mori A, eds. Oxidative stress and aging. Basel: Birkhäuser Verlag, 1995. 1-14.
42. Halliwell B, Gutteridge JMC. Free radicals in biology and medicine. Oxford: Oxford Science, 1999.
43. Dizdaroglu M. Oxidative damage to DNA in mammalian chromatin. Mutat Res 1992;275:331-42.
44. Breen AP, Murphy JA. Reactions of oxyl radicals with DNA. Free Radic Biol Med 1995;18:1033-77.
45. Hasty P, Vijg J. Genomic priorities in aging. Science 2002;296:1250-1.
46. Dizdaroglu M, Jaruga P, Birincioglu M, Rodriguez H. Free radical-induced damage to DNA: mechanisms and measurement. Free Radic Biol Med 2002;32:1102-15.
47. Wozniak K, Blasiak J. Free radicals-mediated induction of oxidized DNA bases and DNA-protein cross-links by nickel chloride. Mutat Res 2002;514:233-43.
48. Cerutti PA. Prooxidant states and tumor promotion. Science 1985;227:375-81.
49. Begleiter A, Sivananthan K, Curphey TJ, Bird RP. Induction of NAD(P)H quinone:oxidoreductase 1 inhibits carcinogen-induced aberrant crypt foci in colons of Sprague-Dawley rats. Cancer Epidemiol Biomarkers Prev 2003;12:566-72.
50. Smith MT, Wang Y, Skibola CF, Slater DJ, Lo Nigro L, Nowell PC, Lange BJ, Felix CA. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children. Blood 2002;100:4590-3.
51. Smith MT, Wang Y, Kane E, Rollinson S, Wiemels JL, Roman E, Roddam P, Cartwright R, Morgan G. Low NAD(P)H:quinone oxidoreductase 1 activity is associated with increased risk of acute leukemia in adults. Blood 2001;97:1422-6.
52. Zhang J, Schulz WA, Li Y, Wang R, Zotz R, Wen D, Siegel D, Ross D, Gabbert HE, Sarbia M. Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis 2003;24:905-9.
53. Maier A, Dalton TP, Puga A. Disruption of dioxin-inducible phase I and phase II gene expression patterns by cadmium, chromium, and arsenic. Mol Carcinog 2000;28:225-35.
54. Bloom D, Dhakshinamoorthy S, Jaiswal AK. Site-directed mutagenesis of cysteine to serine in the DNA binding region of Nrf2 decreases its capacity to upregulate antioxidant response element-mediated expression and antioxidant induction of NAD(P)H:quinone oxidoreductase 1 gene. Oncogene 2002;28:2191-200.
55. Jaruga P, Birincioglu M, Rodriguez H, Dizdaroglu M. Mass spectrometric assays for the tandem lesion 8,5′-cyclo-2′-deoxyguanosine in mammalian DNA. Biochemistry 2002;41:3703-11.
56. Cotgreave IA, Moldeus P, Orrenius S. Host biochemical defense mechanisms against prooxidants. Annu Rev Pharmacol Toxicol 1988;28:189-212.
57. Sies H. Strategies of antioxidant defense. Eur J Biochem 1993;215:213-9.
58. Parkinson A. Biotransformation of xenobiotics. In: Klaassen CD, ed. Carsarett and Doull's toxicology: the basic science of poisons. New York: McGraw-Hill, 2001. 133-224.
59. Brockstedt U, Krajinovic M, Richer C, Mathonnet G, Sinnett D, Pfau W, Labuda D. Analyses of bulky DNA adduct levels in human breast tissue and genetic polymorphisms of cytochromes P450 (CYPs), myeloperoxidase (MPO), quinone oxidoreductase (NQO1), and glutathione S-transferases (GSTs). Mutat Res 2002;516:41-7.
60. Abou-Donia MB, Elmasry EM, Abu-Qare AW. Metabolism and toxicokinetics of xenobiotics. In: Derelanko MJ, Hollinger MA, eds. Handbook of toxicology. Boca Raton: CRC Press, 2002. 769-833.
61. Gaikwad A, Long II DJ, Stringer JL, Jaiswal AK. In vivo role of NAD(P)H:quinone oxidoreductase 1 (NQO1) in the regulation of intracellular redox state and accumulation of abdominal adipose tissue. J Biol Chem 2001;276:22559-64.
62. Lindahl T. Instability and decay of the primary structure of DNA. Nature 1993;362:709-15.